Innate Pharma (IPHA) Receivables (2017 - 2026)
Innate Pharma's Receivables was $10.26 million in the quarter ended Jun 30, 2026, down 46.6% from $19.23 million a year earlier.
Powered by 
Analysis
Innate Pharma (IPHA) Receivables (2017 - 2026) Analysis & Trends
As of Dec 31, 2025, Receivables at Innate Pharma came in at $14.29 million, down 7.7% from the prior year.
- Receivables shows a five-year compound annual growth rate of -24.7% (years ended Dec 2020 to Dec 2025).
- In earlier years, Receivables was $15.48 million in the year ended Dec 31, 2024 (-78.4%), $71.51 million in the year ended Dec 31, 2023 (+29.4%), $55.27 million in the year ended Dec 31, 2022 (+0.2%) and $55.19 million in the year ended Dec 31, 2021 (-6.4%).
- The figure for the quarter ended Jun 30, 2026 marks the lowest quarterly Receivables in data going back to the quarter ended Dec 31, 2017.
- The best year-over-year quarter for Receivables over five years was the quarter ended Dec 31, 2023 (growth of 32.9%); the worst was the quarter ended Dec 31, 2024 (a decline of 78.5%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,130.87 Bn | 1,099.45 Bn | 19.71 Bn | 23.48 Bn |
| 2 | Johnson & Johnson | 614.49 Bn | 533.02 Bn | 17.26 Bn | 19.05 Bn |
| 3 | AbbVie | 502.45 Bn | 475.56 Bn | 12.70 Bn | 13.82 Bn |
| 4 | Merck | 368.35 Bn | 322.73 Bn | 12.21 Bn | 12.56 Bn |
| 5 | Novartis Ag | 298.42 Bn | 262.41 Bn | 11.24 Bn | 9.64 Bn |
| 6 | Astrazeneca | 261.95 Bn | 235.64 Bn | 12.86 Bn | 15.68 Bn |
| 7 | Amgen | 235.96 Bn | 191.36 Bn | 7.24 Bn | 10.23 Bn |
| 8 | Gilead Sciences | 191.17 Bn | 165.37 Bn | 6.22 Bn | 5.06 Bn |
| 9 | Pfizer | 169.80 Bn | 116.45 Bn | 10.94 Bn | 12.49 Bn |
| 10 | Innate Pharma | 140.75 Mn | -66.45 Mn | - | 10.09 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 10.09 Mn |
| Dec 31, 2025 | 14.57 Mn |
| Jun 30, 2025 | 19.92 Mn |
| Dec 31, 2024 | 5.17 Mn |
| Jun 30, 2024 | 36.70 Mn |
| Dec 31, 2023 | 61.49 Mn |
| Jun 30, 2023 | 61.35 Mn |
| Dec 31, 2022 | 40.88 Mn |
| Jun 30, 2022 | 64.28 Mn |
| Dec 31, 2021 | 20.86 Mn |
| Jun 30, 2021 | 53.70 Mn |
| Dec 31, 2020 | 26.83 Mn |
| Jun 30, 2020 | 44.31 Mn |
| Dec 31, 2019 | 20.99 Mn |
| Dec 31, 2018 | 174.02 Mn |
| Dec 31, 2017 | 25.57 Mn |
API Access
Innate Pharma Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables&ticker=IPHA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables", "ticker": "IPHA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables&ticker=IPHA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();